|
Market Closed -
Nasdaq
04:00:00 30/10/2026 HKT
|
Pre-market 17:51:15 | |||
| 56.49 USD | -1.40% |
|
57.29 | +1.42% |
| 10-29 | Deutsche Bank raises price target for Genmab to DKK 4,000 (3,500), reiterates buy - BN | FW |
| 10-29 | AlphaValue/Baader Europe Downgrades Genmab to Sell | MT |
Company Valuation: Genmab A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 172,063 | 192,229 | 140,770 | 94,810 | 124,862 | 226,349 | - | - |
| Change | - | 11.72% | -26.77% | -32.65% | 31.7% | 81.28% | - | - |
| Enterprise Value (EV) 1 | 152,725 | 169,905 | 112,635 | 73,709 | 114,029 | 245,975 | 237,722 | 224,383 |
| Change | - | 11.25% | -33.71% | -34.56% | 54.7% | 115.71% | -3.36% | -5.61% |
| P/E | 57.8x | 35.2x | 32.6x | 12.3x | 20.9x | 46x | 31.3x | 19.6x |
| PBR | 7.82x | 7.07x | 4.5x | 2.68x | 3.47x | 5.42x | 4.61x | 3.75x |
| PEG | - | 0.4x | -1.5x | 0.1x | -1x | -3x | 0.7x | 0.3x |
| Capitalization / Revenue | 20.3x | 13.2x | 8.54x | 4.4x | 5.31x | 7.51x | 6.24x | 4.81x |
| EV / Revenue | 18x | 11.6x | 6.84x | 3.42x | 4.85x | 8.16x | 6.55x | 4.77x |
| EV / EBITDA | 46.8x | 25.3x | 20.1x | 10.4x | 15.9x | 27.3x | 18.8x | 12.2x |
| EV / EBIT | 50.6x | 26.7x | 21.2x | 10.5x | 17x | 30.2x | 21.6x | 14x |
| EV / FCF | 77.3x | 47.3x | 16.1x | 9.72x | 15.7x | 40.2x | 30x | 16.9x |
| FCF Yield | 1.29% | 2.12% | 6.23% | 10.3% | 6.36% | 2.48% | 3.33% | 5.92% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 45.54 | 83.65 | 66.02 | 121.4 | 97.08 | 82.26 | 120.9 | 193.1 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 8,482 | 14,595 | 16,474 | 21,526 | 23,497 | 30,148 | 36,287 | 47,047 |
| EBITDA 1 | 3,266 | 6,719 | 5,616 | 7,116 | 7,175 | 9,001 | 12,624 | 18,451 |
| EBIT 1 | 3,018 | 6,357 | 5,321 | 7,003 | 6,727 | 8,142 | 10,988 | 16,073 |
| Net income 1 | 3,008 | 5,522 | 4,352 | 7,844 | 6,083 | 5,167 | 7,798 | 12,131 |
| Net Debt 1 | -19,338 | -22,324 | -28,135 | -21,101 | -10,833 | 19,626 | 11,373 | -1,966 |
| Reference price 2 | 2,630.00 | 2,941.00 | 2,155.00 | 1,492.50 | 2,027.00 | 3,788.00 | 3,788.00 | 3,788.00 |
| Nbr of stocks (in thousands) | 65,423 | 65,362 | 65,322 | 63,524 | 61,599 | 59,754 | - | - |
| Announcement Date | 16/2/22 | 22/2/23 | 14/2/24 | 12/2/25 | 17/2/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.97x | 6.42x | 12.3x | 1.76% | 64.38B | |
| 30.03x | 8.21x | 26.91x | 0.04% | 56.16B | |
| 37.32x | 6.62x | 19.78x | 0.87% | 54.16B | |
| 35.94x | 3.4x | 14.66x | -.--% | 45.33B | |
| 49.01x | 5.65x | 30.93x | -.--% | 42.25B | |
| -19.75x | 191.25x | -21.04x | -.--% | 40.78B | |
| 46.05x | 8.16x | 27.33x | -.--% | 33.8B | |
| 31.61x | 8.04x | 20.91x | 0.41% | 32.25B | |
| 27.18x | 5.72x | 14.84x | -.--% | 23.57B | |
| Average | 28.26x | 27.05x | 16.29x | 0.34% | 43.63B | |
| Weighted average by Cap. | 27.79x | 25.71x | 16.39x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Valuation Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
